Review



anti human interferon lambda receptor 1 neutralizing antibody  (PBL Assay)


Bioz Verified Symbol PBL Assay is a verified supplier
Bioz Manufacturer Symbol PBL Assay manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    PBL Assay anti human interferon lambda receptor 1 neutralizing antibody
    Wild-type (WT) and Plscr1 -/- mice were exposed to sublethal (300 pfu) influenza A virus (IAV) (WSN) infection. ( A ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( B ) Differential cell counts in BAL. ( C ) Representative lung sections stained with Hematoxylin and Eosin (H&E). Scale bars represent 3 mm (main) and 200 μm (inlays). ( D ) Whole lungs were analyzed for Ifna , Ifnb , Ifng, and <t>Ifnl</t> RNA by qRT-PCR. ( E ) Tnf-α and Ifn-λ concentrations in BAL by ELISA. Data are expressed as mean ± SEM of n=3–14 mice/group. All data were pooled from three independent experiments and described biological replicates. * p <0.05, ** p <0.01. dpi, days post-infection.
    Anti Human Interferon Lambda Receptor 1 Neutralizing Antibody, supplied by PBL Assay, used in various techniques. Bioz Stars score: 93/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-human+interferon+lambda+receptor+1+neutralizing+antibody/Anti-Human+Interferon+Lambda+Receptor+1%2C+Clone+MMHLR-1/pmc12736948-353-12-19
    Average 93 stars, based on 8 article reviews
    anti human interferon lambda receptor 1 neutralizing antibody - by Bioz Stars, 2026-10
    93/100 stars

    Images

    1) Product Images from "Phospholipid scramblase 1 (PLSCR1) regulates interferon-lambda receptor 1 (IFN-λR1) and IFN-λ signaling in influenza A virus (IAV) infection"

    Article Title: Phospholipid scramblase 1 (PLSCR1) regulates interferon-lambda receptor 1 (IFN-λR1) and IFN-λ signaling in influenza A virus (IAV) infection

    Journal: eLife

    doi: 10.7554/eLife.104359

    Wild-type (WT) and Plscr1 -/- mice were exposed to sublethal (300 pfu) influenza A virus (IAV) (WSN) infection. ( A ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( B ) Differential cell counts in BAL. ( C ) Representative lung sections stained with Hematoxylin and Eosin (H&E). Scale bars represent 3 mm (main) and 200 μm (inlays). ( D ) Whole lungs were analyzed for Ifna , Ifnb , Ifng, and Ifnl RNA by qRT-PCR. ( E ) Tnf-α and Ifn-λ concentrations in BAL by ELISA. Data are expressed as mean ± SEM of n=3–14 mice/group. All data were pooled from three independent experiments and described biological replicates. * p <0.05, ** p <0.01. dpi, days post-infection.
    Figure Legend Snippet: Wild-type (WT) and Plscr1 -/- mice were exposed to sublethal (300 pfu) influenza A virus (IAV) (WSN) infection. ( A ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( B ) Differential cell counts in BAL. ( C ) Representative lung sections stained with Hematoxylin and Eosin (H&E). Scale bars represent 3 mm (main) and 200 μm (inlays). ( D ) Whole lungs were analyzed for Ifna , Ifnb , Ifng, and Ifnl RNA by qRT-PCR. ( E ) Tnf-α and Ifn-λ concentrations in BAL by ELISA. Data are expressed as mean ± SEM of n=3–14 mice/group. All data were pooled from three independent experiments and described biological replicates. * p <0.05, ** p <0.01. dpi, days post-infection.

    Techniques Used: Virus, Infection, Staining, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay

    Wild-type (WT) and Plscr1-/- mice were intranasally given 2.5 μg/g of body weight of poly(I:C) (HMW) constitutively for 6 days and sacrificed on day 7. ( A ) Scheme of experiment. ( B ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( C ) Differential cell counts in BAL. ( D, F, G ) Whole lungs were analyzed for Ifna, Ifnb, Ifng, Ifnl ( D ); Plscr1 ( F ); and Ifnlr1 ( G ) RNA by qRT-PCR. ( E ) Representative lung sections stained with Hematoxylin and Eosin (H&E). Scale bars represent 3 mm (main) and 200 μm (inlays). Data are expressed as mean ± SEM of n=5–12 mice/group. All data were pooled from three independent experiments and described biological replicates. ns, not significant, *p<0.05, ***p<0.001.
    Figure Legend Snippet: Wild-type (WT) and Plscr1-/- mice were intranasally given 2.5 μg/g of body weight of poly(I:C) (HMW) constitutively for 6 days and sacrificed on day 7. ( A ) Scheme of experiment. ( B ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( C ) Differential cell counts in BAL. ( D, F, G ) Whole lungs were analyzed for Ifna, Ifnb, Ifng, Ifnl ( D ); Plscr1 ( F ); and Ifnlr1 ( G ) RNA by qRT-PCR. ( E ) Representative lung sections stained with Hematoxylin and Eosin (H&E). Scale bars represent 3 mm (main) and 200 μm (inlays). Data are expressed as mean ± SEM of n=5–12 mice/group. All data were pooled from three independent experiments and described biological replicates. ns, not significant, *p<0.05, ***p<0.001.

    Techniques Used: Quantitative RT-PCR, Staining

    Plscr1 floxStop and Plscr1 floxStop ;Foxj1-Cre + mice were exposed to sublethal (300 pfu) influenza A virus (IAV) (WSN) infection and sacrificed at 3 dpi. ( A ) Schematic representation of the experimental design of ciliated epithelial cell conditional Plscr1 KI mice. ( B ) Validation of Plscr1 overexpression in lungs of Plscr1 floxStop ;Foxj1-Cre + mice by qRT-PCR. ( C ) Representative immunofluorescent staining for Plscr1, Ifn-λr1, and Foxj1 in lungs. Scale bars represent 50 μm (main) and 10 μm (inlays).( D ) Mean relative weight of mice. ( E ) Viral RNA load in the lungs was assessed by quantifying M gene by qRT-PCR. ( F ) Infectious viral titer in the lungs was assessed by plaque assays. ( G ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( H ) Neutrophil percentages in BAL. ( I ) Whole lungs were analyzed for Ifnlr1 RNA by qRT-PCR and Ifn-λr1 protein by western blot. ( J ) Whole lungs were analyzed for Ifna , Ifnb , Ifng , and Ifnl RNA by qRT-PCR. ( K ) Model depicting proposed mechanism of PLSCR1-regulated IFN-λ signaling. Data are expressed as mean ± SEM of n=3–10 mice/group. All data were pooled from three independent experiments and described biological replicates. ns, not significant, * p <0.05, ** p <0.01, *** p <0.001. dpi, days post-infection. Figure 8—source data 1. PDF file containing original membrane for , indicating the relevant bands and treatments. The membrane was cut just under 50 kDa marker after transfer. The top part was incubated with α-Ifn-λr1 antibody and the bottom part was incubated with α-β-actin antibody. They were then incubated with corresponding secondary antibodies separately. The exposure time was adjusted to visualize Ifn-λr1 (top) or β-actin (middle). A colorimetric photo was taken to visualize the molecular weight markers (bottom). Lanes 2 and 3 were from an unrelated experiment. Figure 8—source data 2. Original membrane corresponding to .
    Figure Legend Snippet: Plscr1 floxStop and Plscr1 floxStop ;Foxj1-Cre + mice were exposed to sublethal (300 pfu) influenza A virus (IAV) (WSN) infection and sacrificed at 3 dpi. ( A ) Schematic representation of the experimental design of ciliated epithelial cell conditional Plscr1 KI mice. ( B ) Validation of Plscr1 overexpression in lungs of Plscr1 floxStop ;Foxj1-Cre + mice by qRT-PCR. ( C ) Representative immunofluorescent staining for Plscr1, Ifn-λr1, and Foxj1 in lungs. Scale bars represent 50 μm (main) and 10 μm (inlays).( D ) Mean relative weight of mice. ( E ) Viral RNA load in the lungs was assessed by quantifying M gene by qRT-PCR. ( F ) Infectious viral titer in the lungs was assessed by plaque assays. ( G ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( H ) Neutrophil percentages in BAL. ( I ) Whole lungs were analyzed for Ifnlr1 RNA by qRT-PCR and Ifn-λr1 protein by western blot. ( J ) Whole lungs were analyzed for Ifna , Ifnb , Ifng , and Ifnl RNA by qRT-PCR. ( K ) Model depicting proposed mechanism of PLSCR1-regulated IFN-λ signaling. Data are expressed as mean ± SEM of n=3–10 mice/group. All data were pooled from three independent experiments and described biological replicates. ns, not significant, * p <0.05, ** p <0.01, *** p <0.001. dpi, days post-infection. Figure 8—source data 1. PDF file containing original membrane for , indicating the relevant bands and treatments. The membrane was cut just under 50 kDa marker after transfer. The top part was incubated with α-Ifn-λr1 antibody and the bottom part was incubated with α-β-actin antibody. They were then incubated with corresponding secondary antibodies separately. The exposure time was adjusted to visualize Ifn-λr1 (top) or β-actin (middle). A colorimetric photo was taken to visualize the molecular weight markers (bottom). Lanes 2 and 3 were from an unrelated experiment. Figure 8—source data 2. Original membrane corresponding to .

    Techniques Used: Virus, Infection, Biomarker Discovery, Over Expression, Quantitative RT-PCR, Staining, Western Blot, Membrane, Marker, Incubation, Molecular Weight

    Plscr1 floxStop and Plscr1 floxStop ;Lyz2-Cre + mice were exposed to sublethal (300 pfu) influenza A virus (IAV) (WSN) infection. ( A ) Validation of Plscr1 overexpression in lungs of Plscr1 floxStop ;Lyz2-Cre + mice by qRT-PCR. ( B ) Mean relative weight of mice. ( C ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( D ) Differential cell counts in BAL. ( E ) Viral RNA load in the lungs was assessed by quantifying M gene by qRT-PCR. ( F ) Representative lung sections stained with Hematoxylin and Eosin (H&E). Scale bars represent 3 mm (main) and 200 μm (inlays). ( G–I ) Whole lungs were analyzed for Ifna , Ifnb , Ifng , Ifnl ( G ); Ifnlr1 ( H ); and Plscr1 ( I ) RNA by qRT-PCR. Data are expressed as mean ± SEM of n=15–16 mice/group for weight loss. For the rest analysis, n=3–7 mice/group. All data were pooled from three independent experiments and described biological replicates. ns, not significant, ** p <0.01. dpi, days post-infection.
    Figure Legend Snippet: Plscr1 floxStop and Plscr1 floxStop ;Lyz2-Cre + mice were exposed to sublethal (300 pfu) influenza A virus (IAV) (WSN) infection. ( A ) Validation of Plscr1 overexpression in lungs of Plscr1 floxStop ;Lyz2-Cre + mice by qRT-PCR. ( B ) Mean relative weight of mice. ( C ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( D ) Differential cell counts in BAL. ( E ) Viral RNA load in the lungs was assessed by quantifying M gene by qRT-PCR. ( F ) Representative lung sections stained with Hematoxylin and Eosin (H&E). Scale bars represent 3 mm (main) and 200 μm (inlays). ( G–I ) Whole lungs were analyzed for Ifna , Ifnb , Ifng , Ifnl ( G ); Ifnlr1 ( H ); and Plscr1 ( I ) RNA by qRT-PCR. Data are expressed as mean ± SEM of n=15–16 mice/group for weight loss. For the rest analysis, n=3–7 mice/group. All data were pooled from three independent experiments and described biological replicates. ns, not significant, ** p <0.01. dpi, days post-infection.

    Techniques Used: Virus, Infection, Biomarker Discovery, Over Expression, Quantitative RT-PCR, Staining

    Influenza infection is usually detected by intracellular pattern recognition receptors (PRRs) such as TLR 3 and 7, RIG-I, and MDA5. These PRRs activate the expression of IFNL in early infection stage through IRF-3 and NK-κB-controlled transcriptions. IFN-λ secreted by the infected cells interacts with IL-10R2 and IFN-λR1 on neighboring cell surfaces, which results in activation of expression of various IFN-stimulated genes, including PLSCR1 . In ciliated airway epithelial cells, PLSCR1 can further enhance the transcription of IFNLR1 by directly binding to its promoter region as a transcriptional factor, or interact with IFN-λR1 on the cell membrane.
    Figure Legend Snippet: Influenza infection is usually detected by intracellular pattern recognition receptors (PRRs) such as TLR 3 and 7, RIG-I, and MDA5. These PRRs activate the expression of IFNL in early infection stage through IRF-3 and NK-κB-controlled transcriptions. IFN-λ secreted by the infected cells interacts with IL-10R2 and IFN-λR1 on neighboring cell surfaces, which results in activation of expression of various IFN-stimulated genes, including PLSCR1 . In ciliated airway epithelial cells, PLSCR1 can further enhance the transcription of IFNLR1 by directly binding to its promoter region as a transcriptional factor, or interact with IFN-λR1 on the cell membrane.

    Techniques Used: Infection, Expressing, Activation Assay, Binding Assay, Membrane

    Related Articles

    other:

    Article Title: HSV-1 and Zika Virus but Not SARS-CoV-2 Replicate in the Human Cornea and Are Restricted by Corneal Type III Interferon
    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Mouse anti-human interferon lambda receptor 1 neutralizing mAb PBL assay science Cat# 21885-1 Unable to locate RRID Mouse IgG1 kappa isotype control mAb Sigma-Aldrich Cat# M7894, RRID:AB_1163632 Bacterial and Virus Strains Herpes simplex virus-1 strain 17+ Bertke et al., 2013 N/A Zika virus, strain Paraiba 2015 (Brazil, 2015) Magnani et al., 2018 N/A SARS-CoV-2 (strain 2019 n-CoV/USA_WA1/2020) CDC/BEI Resources NR52281 Biological Samples Human corneas Mid-America Transplant Institute N/A Chemicals, Peptides, and Recombinant Proteins Recombinant Human IL-29/IFN Lambda 1, HCE PBL assay science Cat# 11725-1 Recombinant Mouse IL-28B/IFN Lambda 3 PBL assay science Cat# 12820-1 Critical Commercial Assays RNeasy Mini Kit QIAGEN Cat# 74104 TaqMan RNA-to-Ct 1-Step Kit ThermoFisher Cat# 4392653 Experimental Models: Cell Lines Vero CCL81 cells ATCC CCL81; RRID: CVCL_0059 Vero E6 cells ATCC CRL-1586; RRID: CVCL_0574 Experimental Models: Organisms/Strains Mouse: Ifnar1 / Jackson Laboratory Cat# JAX:032048, RRID: IMSR_JAX:032048 Mouse: AG129 Marshall BioResources AG129 Mouse: Ifnlr1 / Baldridge et al., 2017 N/A Oligonucleotides SARS-CoV-2 N F: 50 -ATGCTGCAATCGTGCTACAA-3 Hassan et al., 2020 N/A SARS-CoV-2 N R: 50 -GACTGCCGCCTCTGCTC-30 Hassan et al., 2020 N/A SARS-CoV-2 N Probe: 50 -/56-FAM/TCAAGGAAC/ZEN/ AACATTGCCAA/3IABkFQ/-30 Hassan et al., 2020 N/A RNAscope Probe- V-ZIKV Advanced Cell Diagnostics Cat# 467771 RNAscope Probe- Hs-IFNLR1 Advanced Cell Diagnostics Cat# 494771 RNAscope Probe- Hs-IFNL1 Advanced Cell Diagnostics Cat# 412341 IFNL1 PrimeTime qPCR Assay Integrated DNA Technologies Hs.PT.56a.21113836.g IFNL2 PrimeTime qPCR Assay Integrated DNA Technologies Hs.PT.56a.38564463 IFNLR1 PrimeTime qPCR Assay Integrated DNA Technologies Hs00417120_m1 IFIT1 PrimeTime qPCR Assay Integrated DNA Technologies Hs.PT.56a.20769090.g IFIT2 PrimeTime qPCR Assay Integrated DNA Technologies Hs.PT.58.1099131 IRF7 PrimeTime qPCR Assay Integrated DNA Technologies Hs.PT.58.24613215.g IFI27 PrimeTime qPCR Assay ThermoFisher Hs01086373_g1 GAPDH PrimeTime qPCR Assay Integrated DNA Technologies Hs.PT.39a.22214936 Ifit1 PrimeTime qPCR Assay Integrated DNA Technologies Mm.PT.58.32674307 Ifit2 PrimeTime qPCR Assay Integrated DNA Technologies Mm.PT.58.45910930.g Ifitm3 PrimeTime qPCR Assay Integrated DNA Technologies Mm.PT.56a.29591636 Irf7 PrimeTime qPCR Assay ThermoFisher Mm00516793 (Continued on next page) e1 Cell Reports 33, 108339, November 3, 2020

    Article Title: HSV-1 and Zika Virus but Not SARS-CoV-2 Replicate in the Human Cornea and Are Restricted by Corneal Type III Interferon
    Article Snippet: Mouse anti-human interferon lambda receptor 1 neutralizing mAb , PBL assay science , Cat# 21885-1 Unable to locate RRID.

    Control:

    Article Title: Phospholipid scramblase 1 (PLSCR1) regulates interferon-lambda receptor 1 (IFN-λR1) and IFN-λ signaling in influenza A virus (IAV) infection
    Article Snippet: Calu-3 or A549 cells were treated with 10 or 100 ng/mL of recombinant human IL-29/IFN-lambda 1 Protein (R&D Systems) for 6 or 24 hr at 37 °C. .. In control Calu-3 groups, cells were first incubated with 1 μg/mL of anti-human interferon lambda receptor 1 neutralizing antibody (PBL Assay Science, cat #21885–1, clone #MMHLR-1) for 1 hr, and then treated with IFN-λ. .. Cryopreserved mouse lungs were homogenized in Pierce RIPA buffer (Thermo Scientific).

    Article Title: Phospholipid Scramblase 1 (PLSCR1) Regulates Interferon-Lambda Receptor 1 (IFN-λR1) and IFN-λ Signaling in Influenza A Virus (IAV) Infection
    Article Snippet: Calu-3 or A549 cells were treated with 10 or 100 ng/mL of recombinant human IL-29/IFN-lambda 1 Protein (R&D Systems) for 6 or 24 hours at 37°C. .. In control Calu-3 groups, cells were first incubated with 1 μg/mL of anti-human interferon lambda receptor 1 neutralizing antibody (PBL Assay Science) for 1 hour, and then treated with IFN-λ. .. Cryopreserved mouse lungs were homogenized in Pierce RIPA buffer (Thermo Scientific).

    Incubation:

    Article Title: Phospholipid scramblase 1 (PLSCR1) regulates interferon-lambda receptor 1 (IFN-λR1) and IFN-λ signaling in influenza A virus (IAV) infection
    Article Snippet: Calu-3 or A549 cells were treated with 10 or 100 ng/mL of recombinant human IL-29/IFN-lambda 1 Protein (R&D Systems) for 6 or 24 hr at 37 °C. .. In control Calu-3 groups, cells were first incubated with 1 μg/mL of anti-human interferon lambda receptor 1 neutralizing antibody (PBL Assay Science, cat #21885–1, clone #MMHLR-1) for 1 hr, and then treated with IFN-λ. .. Cryopreserved mouse lungs were homogenized in Pierce RIPA buffer (Thermo Scientific).

    Article Title: Phospholipid Scramblase 1 (PLSCR1) Regulates Interferon-Lambda Receptor 1 (IFN-λR1) and IFN-λ Signaling in Influenza A Virus (IAV) Infection
    Article Snippet: Calu-3 or A549 cells were treated with 10 or 100 ng/mL of recombinant human IL-29/IFN-lambda 1 Protein (R&D Systems) for 6 or 24 hours at 37°C. .. In control Calu-3 groups, cells were first incubated with 1 μg/mL of anti-human interferon lambda receptor 1 neutralizing antibody (PBL Assay Science) for 1 hour, and then treated with IFN-λ. .. Cryopreserved mouse lungs were homogenized in Pierce RIPA buffer (Thermo Scientific).

    Recombinant:

    Article Title: Interferon-independent processes constrain measles virus cell-to-cell spread in primary human airway epithelial cells
    Article Snippet: .. To induce IFN-blocking, MeV-infected HAE cultures were treated apically with 2 μg/mL recombinant B18R protein (StemCell Technologies cat# 78075) or 50 ng/mL monoclonal anti-human IFN-λ1 neutralizing antibody (clone MMHLR1, PBL Assay Science, Piscataway, NJ, cat# 21885-1). .. At indicated timepoints, TRIzol reagent (Thermo Fisher Scientific cat# 15596026) was added to the apical surface of cells.



    Similar Products

    93
    PBL Assay anti human interferon lambda receptor 1 neutralizing antibody
    Wild-type (WT) and Plscr1 -/- mice were exposed to sublethal (300 pfu) influenza A virus (IAV) (WSN) infection. ( A ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( B ) Differential cell counts in BAL. ( C ) Representative lung sections stained with Hematoxylin and Eosin (H&E). Scale bars represent 3 mm (main) and 200 μm (inlays). ( D ) Whole lungs were analyzed for Ifna , Ifnb , Ifng, and <t>Ifnl</t> RNA by qRT-PCR. ( E ) Tnf-α and Ifn-λ concentrations in BAL by ELISA. Data are expressed as mean ± SEM of n=3–14 mice/group. All data were pooled from three independent experiments and described biological replicates. * p <0.05, ** p <0.01. dpi, days post-infection.
    Anti Human Interferon Lambda Receptor 1 Neutralizing Antibody, supplied by PBL Assay, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-human+interferon+lambda+receptor+1+neutralizing+antibody/Anti-Human+Interferon+Lambda+Receptor+1%2C+Clone+MMHLR-1/pmc12736948-353-12-19
    Average 93 stars, based on 1 article reviews
    anti human interferon lambda receptor 1 neutralizing antibody - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    PBL Assay monoclonal anti human ifn λ1 neutralizing antibody
    MeV is susceptible to exogenous <t>IFN</t> treatment. ( A ) HAE were infected at the basolateral surface with MeV expressing GFP upstream of N-protein (1 MOI) or ( B ) apical surface with RSV expressing GFP upstream of N-protein (1 MOI). Recombinant IFN-β (100 ng/mL), IFN-λ (2 µg/mL), or PBS vehicle (mock) were added to the apical surface of cultures at 18 hpi. Treatment lasted 24 h. Transwells were imaged 2–5 dpi. ( A ) Infectious center size or ( B ) fluorescence intensity was quantified using ImageJ software. Images were blinded in ImageJ prior to measurements using a blind-analysis tool. Measurements were unblinded just prior to GraphPad Prism input. n = 3 donors, indicated by color. Representative low power images for each treatment are shown. Scale bar = 500 µm. Significance was determined by one-way ANOVA with Tukey’s multiple comparison corrections.
    Monoclonal Anti Human Ifn λ1 Neutralizing Antibody, supplied by PBL Assay, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-human+interferon+lambda+receptor+1+neutralizing+antibody/Anti-Human+Interferon+Lambda+Receptor+1%2C+Clone+MMHLR-1/pmc10580916-219-22-29
    Average 93 stars, based on 1 article reviews
    monoclonal anti human ifn λ1 neutralizing antibody - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    PBL Assay anti-human interferon lambda receptor 1, clone mmhlr-1
    MeV is susceptible to exogenous <t>IFN</t> treatment. ( A ) HAE were infected at the basolateral surface with MeV expressing GFP upstream of N-protein (1 MOI) or ( B ) apical surface with RSV expressing GFP upstream of N-protein (1 MOI). Recombinant IFN-β (100 ng/mL), IFN-λ (2 µg/mL), or PBS vehicle (mock) were added to the apical surface of cultures at 18 hpi. Treatment lasted 24 h. Transwells were imaged 2–5 dpi. ( A ) Infectious center size or ( B ) fluorescence intensity was quantified using ImageJ software. Images were blinded in ImageJ prior to measurements using a blind-analysis tool. Measurements were unblinded just prior to GraphPad Prism input. n = 3 donors, indicated by color. Representative low power images for each treatment are shown. Scale bar = 500 µm. Significance was determined by one-way ANOVA with Tukey’s multiple comparison corrections.
    Anti Human Interferon Lambda Receptor 1, Clone Mmhlr 1, supplied by PBL Assay, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-human+interferon+lambda+receptor+1+neutralizing+antibody/Anti-Human+Interferon+Lambda+Receptor+1%2C+Clone+MMHLR-1/custom%4021885-1%4031199715
    Average 93 stars, based on 1 article reviews
    anti-human interferon lambda receptor 1, clone mmhlr-1 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    Image Search Results


    Wild-type (WT) and Plscr1 -/- mice were exposed to sublethal (300 pfu) influenza A virus (IAV) (WSN) infection. ( A ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( B ) Differential cell counts in BAL. ( C ) Representative lung sections stained with Hematoxylin and Eosin (H&E). Scale bars represent 3 mm (main) and 200 μm (inlays). ( D ) Whole lungs were analyzed for Ifna , Ifnb , Ifng, and Ifnl RNA by qRT-PCR. ( E ) Tnf-α and Ifn-λ concentrations in BAL by ELISA. Data are expressed as mean ± SEM of n=3–14 mice/group. All data were pooled from three independent experiments and described biological replicates. * p <0.05, ** p <0.01. dpi, days post-infection.

    Journal: eLife

    Article Title: Phospholipid scramblase 1 (PLSCR1) regulates interferon-lambda receptor 1 (IFN-λR1) and IFN-λ signaling in influenza A virus (IAV) infection

    doi: 10.7554/eLife.104359

    Figure Lengend Snippet: Wild-type (WT) and Plscr1 -/- mice were exposed to sublethal (300 pfu) influenza A virus (IAV) (WSN) infection. ( A ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( B ) Differential cell counts in BAL. ( C ) Representative lung sections stained with Hematoxylin and Eosin (H&E). Scale bars represent 3 mm (main) and 200 μm (inlays). ( D ) Whole lungs were analyzed for Ifna , Ifnb , Ifng, and Ifnl RNA by qRT-PCR. ( E ) Tnf-α and Ifn-λ concentrations in BAL by ELISA. Data are expressed as mean ± SEM of n=3–14 mice/group. All data were pooled from three independent experiments and described biological replicates. * p <0.05, ** p <0.01. dpi, days post-infection.

    Article Snippet: In control Calu-3 groups, cells were first incubated with 1 μg/mL of anti-human interferon lambda receptor 1 neutralizing antibody (PBL Assay Science, cat #21885–1, clone #MMHLR-1) for 1 hr, and then treated with IFN-λ.

    Techniques: Virus, Infection, Staining, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay

    Wild-type (WT) and Plscr1-/- mice were intranasally given 2.5 μg/g of body weight of poly(I:C) (HMW) constitutively for 6 days and sacrificed on day 7. ( A ) Scheme of experiment. ( B ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( C ) Differential cell counts in BAL. ( D, F, G ) Whole lungs were analyzed for Ifna, Ifnb, Ifng, Ifnl ( D ); Plscr1 ( F ); and Ifnlr1 ( G ) RNA by qRT-PCR. ( E ) Representative lung sections stained with Hematoxylin and Eosin (H&E). Scale bars represent 3 mm (main) and 200 μm (inlays). Data are expressed as mean ± SEM of n=5–12 mice/group. All data were pooled from three independent experiments and described biological replicates. ns, not significant, *p<0.05, ***p<0.001.

    Journal: eLife

    Article Title: Phospholipid scramblase 1 (PLSCR1) regulates interferon-lambda receptor 1 (IFN-λR1) and IFN-λ signaling in influenza A virus (IAV) infection

    doi: 10.7554/eLife.104359

    Figure Lengend Snippet: Wild-type (WT) and Plscr1-/- mice were intranasally given 2.5 μg/g of body weight of poly(I:C) (HMW) constitutively for 6 days and sacrificed on day 7. ( A ) Scheme of experiment. ( B ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( C ) Differential cell counts in BAL. ( D, F, G ) Whole lungs were analyzed for Ifna, Ifnb, Ifng, Ifnl ( D ); Plscr1 ( F ); and Ifnlr1 ( G ) RNA by qRT-PCR. ( E ) Representative lung sections stained with Hematoxylin and Eosin (H&E). Scale bars represent 3 mm (main) and 200 μm (inlays). Data are expressed as mean ± SEM of n=5–12 mice/group. All data were pooled from three independent experiments and described biological replicates. ns, not significant, *p<0.05, ***p<0.001.

    Article Snippet: In control Calu-3 groups, cells were first incubated with 1 μg/mL of anti-human interferon lambda receptor 1 neutralizing antibody (PBL Assay Science, cat #21885–1, clone #MMHLR-1) for 1 hr, and then treated with IFN-λ.

    Techniques: Quantitative RT-PCR, Staining

    Plscr1 floxStop and Plscr1 floxStop ;Foxj1-Cre + mice were exposed to sublethal (300 pfu) influenza A virus (IAV) (WSN) infection and sacrificed at 3 dpi. ( A ) Schematic representation of the experimental design of ciliated epithelial cell conditional Plscr1 KI mice. ( B ) Validation of Plscr1 overexpression in lungs of Plscr1 floxStop ;Foxj1-Cre + mice by qRT-PCR. ( C ) Representative immunofluorescent staining for Plscr1, Ifn-λr1, and Foxj1 in lungs. Scale bars represent 50 μm (main) and 10 μm (inlays).( D ) Mean relative weight of mice. ( E ) Viral RNA load in the lungs was assessed by quantifying M gene by qRT-PCR. ( F ) Infectious viral titer in the lungs was assessed by plaque assays. ( G ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( H ) Neutrophil percentages in BAL. ( I ) Whole lungs were analyzed for Ifnlr1 RNA by qRT-PCR and Ifn-λr1 protein by western blot. ( J ) Whole lungs were analyzed for Ifna , Ifnb , Ifng , and Ifnl RNA by qRT-PCR. ( K ) Model depicting proposed mechanism of PLSCR1-regulated IFN-λ signaling. Data are expressed as mean ± SEM of n=3–10 mice/group. All data were pooled from three independent experiments and described biological replicates. ns, not significant, * p <0.05, ** p <0.01, *** p <0.001. dpi, days post-infection. Figure 8—source data 1. PDF file containing original membrane for , indicating the relevant bands and treatments. The membrane was cut just under 50 kDa marker after transfer. The top part was incubated with α-Ifn-λr1 antibody and the bottom part was incubated with α-β-actin antibody. They were then incubated with corresponding secondary antibodies separately. The exposure time was adjusted to visualize Ifn-λr1 (top) or β-actin (middle). A colorimetric photo was taken to visualize the molecular weight markers (bottom). Lanes 2 and 3 were from an unrelated experiment. Figure 8—source data 2. Original membrane corresponding to .

    Journal: eLife

    Article Title: Phospholipid scramblase 1 (PLSCR1) regulates interferon-lambda receptor 1 (IFN-λR1) and IFN-λ signaling in influenza A virus (IAV) infection

    doi: 10.7554/eLife.104359

    Figure Lengend Snippet: Plscr1 floxStop and Plscr1 floxStop ;Foxj1-Cre + mice were exposed to sublethal (300 pfu) influenza A virus (IAV) (WSN) infection and sacrificed at 3 dpi. ( A ) Schematic representation of the experimental design of ciliated epithelial cell conditional Plscr1 KI mice. ( B ) Validation of Plscr1 overexpression in lungs of Plscr1 floxStop ;Foxj1-Cre + mice by qRT-PCR. ( C ) Representative immunofluorescent staining for Plscr1, Ifn-λr1, and Foxj1 in lungs. Scale bars represent 50 μm (main) and 10 μm (inlays).( D ) Mean relative weight of mice. ( E ) Viral RNA load in the lungs was assessed by quantifying M gene by qRT-PCR. ( F ) Infectious viral titer in the lungs was assessed by plaque assays. ( G ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( H ) Neutrophil percentages in BAL. ( I ) Whole lungs were analyzed for Ifnlr1 RNA by qRT-PCR and Ifn-λr1 protein by western blot. ( J ) Whole lungs were analyzed for Ifna , Ifnb , Ifng , and Ifnl RNA by qRT-PCR. ( K ) Model depicting proposed mechanism of PLSCR1-regulated IFN-λ signaling. Data are expressed as mean ± SEM of n=3–10 mice/group. All data were pooled from three independent experiments and described biological replicates. ns, not significant, * p <0.05, ** p <0.01, *** p <0.001. dpi, days post-infection. Figure 8—source data 1. PDF file containing original membrane for , indicating the relevant bands and treatments. The membrane was cut just under 50 kDa marker after transfer. The top part was incubated with α-Ifn-λr1 antibody and the bottom part was incubated with α-β-actin antibody. They were then incubated with corresponding secondary antibodies separately. The exposure time was adjusted to visualize Ifn-λr1 (top) or β-actin (middle). A colorimetric photo was taken to visualize the molecular weight markers (bottom). Lanes 2 and 3 were from an unrelated experiment. Figure 8—source data 2. Original membrane corresponding to .

    Article Snippet: In control Calu-3 groups, cells were first incubated with 1 μg/mL of anti-human interferon lambda receptor 1 neutralizing antibody (PBL Assay Science, cat #21885–1, clone #MMHLR-1) for 1 hr, and then treated with IFN-λ.

    Techniques: Virus, Infection, Biomarker Discovery, Over Expression, Quantitative RT-PCR, Staining, Western Blot, Membrane, Marker, Incubation, Molecular Weight

    Plscr1 floxStop and Plscr1 floxStop ;Lyz2-Cre + mice were exposed to sublethal (300 pfu) influenza A virus (IAV) (WSN) infection. ( A ) Validation of Plscr1 overexpression in lungs of Plscr1 floxStop ;Lyz2-Cre + mice by qRT-PCR. ( B ) Mean relative weight of mice. ( C ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( D ) Differential cell counts in BAL. ( E ) Viral RNA load in the lungs was assessed by quantifying M gene by qRT-PCR. ( F ) Representative lung sections stained with Hematoxylin and Eosin (H&E). Scale bars represent 3 mm (main) and 200 μm (inlays). ( G–I ) Whole lungs were analyzed for Ifna , Ifnb , Ifng , Ifnl ( G ); Ifnlr1 ( H ); and Plscr1 ( I ) RNA by qRT-PCR. Data are expressed as mean ± SEM of n=15–16 mice/group for weight loss. For the rest analysis, n=3–7 mice/group. All data were pooled from three independent experiments and described biological replicates. ns, not significant, ** p <0.01. dpi, days post-infection.

    Journal: eLife

    Article Title: Phospholipid scramblase 1 (PLSCR1) regulates interferon-lambda receptor 1 (IFN-λR1) and IFN-λ signaling in influenza A virus (IAV) infection

    doi: 10.7554/eLife.104359

    Figure Lengend Snippet: Plscr1 floxStop and Plscr1 floxStop ;Lyz2-Cre + mice were exposed to sublethal (300 pfu) influenza A virus (IAV) (WSN) infection. ( A ) Validation of Plscr1 overexpression in lungs of Plscr1 floxStop ;Lyz2-Cre + mice by qRT-PCR. ( B ) Mean relative weight of mice. ( C ) Total Bronchoalveolar lavage (BAL) leukocyte numbers. ( D ) Differential cell counts in BAL. ( E ) Viral RNA load in the lungs was assessed by quantifying M gene by qRT-PCR. ( F ) Representative lung sections stained with Hematoxylin and Eosin (H&E). Scale bars represent 3 mm (main) and 200 μm (inlays). ( G–I ) Whole lungs were analyzed for Ifna , Ifnb , Ifng , Ifnl ( G ); Ifnlr1 ( H ); and Plscr1 ( I ) RNA by qRT-PCR. Data are expressed as mean ± SEM of n=15–16 mice/group for weight loss. For the rest analysis, n=3–7 mice/group. All data were pooled from three independent experiments and described biological replicates. ns, not significant, ** p <0.01. dpi, days post-infection.

    Article Snippet: In control Calu-3 groups, cells were first incubated with 1 μg/mL of anti-human interferon lambda receptor 1 neutralizing antibody (PBL Assay Science, cat #21885–1, clone #MMHLR-1) for 1 hr, and then treated with IFN-λ.

    Techniques: Virus, Infection, Biomarker Discovery, Over Expression, Quantitative RT-PCR, Staining

    Influenza infection is usually detected by intracellular pattern recognition receptors (PRRs) such as TLR 3 and 7, RIG-I, and MDA5. These PRRs activate the expression of IFNL in early infection stage through IRF-3 and NK-κB-controlled transcriptions. IFN-λ secreted by the infected cells interacts with IL-10R2 and IFN-λR1 on neighboring cell surfaces, which results in activation of expression of various IFN-stimulated genes, including PLSCR1 . In ciliated airway epithelial cells, PLSCR1 can further enhance the transcription of IFNLR1 by directly binding to its promoter region as a transcriptional factor, or interact with IFN-λR1 on the cell membrane.

    Journal: eLife

    Article Title: Phospholipid scramblase 1 (PLSCR1) regulates interferon-lambda receptor 1 (IFN-λR1) and IFN-λ signaling in influenza A virus (IAV) infection

    doi: 10.7554/eLife.104359

    Figure Lengend Snippet: Influenza infection is usually detected by intracellular pattern recognition receptors (PRRs) such as TLR 3 and 7, RIG-I, and MDA5. These PRRs activate the expression of IFNL in early infection stage through IRF-3 and NK-κB-controlled transcriptions. IFN-λ secreted by the infected cells interacts with IL-10R2 and IFN-λR1 on neighboring cell surfaces, which results in activation of expression of various IFN-stimulated genes, including PLSCR1 . In ciliated airway epithelial cells, PLSCR1 can further enhance the transcription of IFNLR1 by directly binding to its promoter region as a transcriptional factor, or interact with IFN-λR1 on the cell membrane.

    Article Snippet: In control Calu-3 groups, cells were first incubated with 1 μg/mL of anti-human interferon lambda receptor 1 neutralizing antibody (PBL Assay Science, cat #21885–1, clone #MMHLR-1) for 1 hr, and then treated with IFN-λ.

    Techniques: Infection, Expressing, Activation Assay, Binding Assay, Membrane

    MeV is susceptible to exogenous IFN treatment. ( A ) HAE were infected at the basolateral surface with MeV expressing GFP upstream of N-protein (1 MOI) or ( B ) apical surface with RSV expressing GFP upstream of N-protein (1 MOI). Recombinant IFN-β (100 ng/mL), IFN-λ (2 µg/mL), or PBS vehicle (mock) were added to the apical surface of cultures at 18 hpi. Treatment lasted 24 h. Transwells were imaged 2–5 dpi. ( A ) Infectious center size or ( B ) fluorescence intensity was quantified using ImageJ software. Images were blinded in ImageJ prior to measurements using a blind-analysis tool. Measurements were unblinded just prior to GraphPad Prism input. n = 3 donors, indicated by color. Representative low power images for each treatment are shown. Scale bar = 500 µm. Significance was determined by one-way ANOVA with Tukey’s multiple comparison corrections.

    Journal: Microbiology Spectrum

    Article Title: Interferon-independent processes constrain measles virus cell-to-cell spread in primary human airway epithelial cells

    doi: 10.1128/spectrum.01361-23

    Figure Lengend Snippet: MeV is susceptible to exogenous IFN treatment. ( A ) HAE were infected at the basolateral surface with MeV expressing GFP upstream of N-protein (1 MOI) or ( B ) apical surface with RSV expressing GFP upstream of N-protein (1 MOI). Recombinant IFN-β (100 ng/mL), IFN-λ (2 µg/mL), or PBS vehicle (mock) were added to the apical surface of cultures at 18 hpi. Treatment lasted 24 h. Transwells were imaged 2–5 dpi. ( A ) Infectious center size or ( B ) fluorescence intensity was quantified using ImageJ software. Images were blinded in ImageJ prior to measurements using a blind-analysis tool. Measurements were unblinded just prior to GraphPad Prism input. n = 3 donors, indicated by color. Representative low power images for each treatment are shown. Scale bar = 500 µm. Significance was determined by one-way ANOVA with Tukey’s multiple comparison corrections.

    Article Snippet: To induce IFN-blocking, MeV-infected HAE cultures were treated apically with 2 μg/mL recombinant B18R protein (StemCell Technologies cat# 78075) or 50 ng/mL monoclonal anti-human IFN-λ1 neutralizing antibody (clone MMHLR1, PBL Assay Science, Piscataway, NJ, cat# 21885-1).

    Techniques: Infection, Expressing, Recombinant, Fluorescence, Software, Comparison

    Blocking IFN in HAE does not increase IC size. ( A ) HAE were infected at the basolateral surface with MeV expressing GFP upstream of N-protein (1 MOI) or ( B ) apical surface with RSV expressing GFP upstream of N-protein (1 MOI). Recombinant B18R (2 µg/mL), anti-λ1 blocking antibody (50 ng/mL), or PBS vehicle (mock) were added to the apical surface of cultures immediately post infection. Treatment lasted 24 h. Transwells were imaged 2–5 dpi. Infectious center size ( A ) or fluorescence intensity ( B ) was quantified using ImageJ software. Images were blinded in ImageJ prior to measurements using a blind-analysis tool. Measurements were unblinded just prior to GraphPad Prism input. n = 3 donors, indicated by color. Representative low power images for each treatment are shown. Scale bar = 500 µm. Significance was determined by one-way ANOVA with Tukey’s multiple comparison corrections.

    Journal: Microbiology Spectrum

    Article Title: Interferon-independent processes constrain measles virus cell-to-cell spread in primary human airway epithelial cells

    doi: 10.1128/spectrum.01361-23

    Figure Lengend Snippet: Blocking IFN in HAE does not increase IC size. ( A ) HAE were infected at the basolateral surface with MeV expressing GFP upstream of N-protein (1 MOI) or ( B ) apical surface with RSV expressing GFP upstream of N-protein (1 MOI). Recombinant B18R (2 µg/mL), anti-λ1 blocking antibody (50 ng/mL), or PBS vehicle (mock) were added to the apical surface of cultures immediately post infection. Treatment lasted 24 h. Transwells were imaged 2–5 dpi. Infectious center size ( A ) or fluorescence intensity ( B ) was quantified using ImageJ software. Images were blinded in ImageJ prior to measurements using a blind-analysis tool. Measurements were unblinded just prior to GraphPad Prism input. n = 3 donors, indicated by color. Representative low power images for each treatment are shown. Scale bar = 500 µm. Significance was determined by one-way ANOVA with Tukey’s multiple comparison corrections.

    Article Snippet: To induce IFN-blocking, MeV-infected HAE cultures were treated apically with 2 μg/mL recombinant B18R protein (StemCell Technologies cat# 78075) or 50 ng/mL monoclonal anti-human IFN-λ1 neutralizing antibody (clone MMHLR1, PBL Assay Science, Piscataway, NJ, cat# 21885-1).

    Techniques: Blocking Assay, Infection, Expressing, Recombinant, Fluorescence, Software, Comparison

    Neither WT MeV nor V KO MeV induces basolateral release of IFN in HAE. HAE were either mock infected or infected with RSV, WT MeV, or V KO MeV (1 MOI) for 4 h. Basolateral media were collected 12 hpi and everyday up to 7 dpi. Basolateral medium was replenished for each culture with fresh media after collection. Samples were analyzed for the presence of ( A ) IFN-α2, ( B ) IFN-β, ( C ) IFN-λ1, and ( D ) IFN-λ2/3. In addition, antiviral cytokines ( E ) CXCL10 and ( F ) IL-6 were analyzed using a human antiviral response panel. Significance was determined by one-way ANOVA with Tukey’s multiple comparison corrections.

    Journal: Microbiology Spectrum

    Article Title: Interferon-independent processes constrain measles virus cell-to-cell spread in primary human airway epithelial cells

    doi: 10.1128/spectrum.01361-23

    Figure Lengend Snippet: Neither WT MeV nor V KO MeV induces basolateral release of IFN in HAE. HAE were either mock infected or infected with RSV, WT MeV, or V KO MeV (1 MOI) for 4 h. Basolateral media were collected 12 hpi and everyday up to 7 dpi. Basolateral medium was replenished for each culture with fresh media after collection. Samples were analyzed for the presence of ( A ) IFN-α2, ( B ) IFN-β, ( C ) IFN-λ1, and ( D ) IFN-λ2/3. In addition, antiviral cytokines ( E ) CXCL10 and ( F ) IL-6 were analyzed using a human antiviral response panel. Significance was determined by one-way ANOVA with Tukey’s multiple comparison corrections.

    Article Snippet: To induce IFN-blocking, MeV-infected HAE cultures were treated apically with 2 μg/mL recombinant B18R protein (StemCell Technologies cat# 78075) or 50 ng/mL monoclonal anti-human IFN-λ1 neutralizing antibody (clone MMHLR1, PBL Assay Science, Piscataway, NJ, cat# 21885-1).

    Techniques: Infection, Comparison

    IFN RNA levels are not elevated during MeV infection of HAE. ( A ) Single-cell RNA sequencing was performed on mock or MeV-infected cultures 3 and 7 dpi. Each MeV-infected culture was FACS sorted into GFP+ or GFP− populations. Intensity shows measure of raw gene transcript counts normalized for the number of cells and total transcript reads in each group (MNA). Every condition included 10 pooled, matched donor HAE cultures, and sequencing was performed with a 10× Genomics scRNA-seq. ( B ) A heat map is shown depicting expression levels for selected innate immune genes measured by RNAseq of MeV-infected HAE. Transcript abundances are expressed as transcripts per million (TPM). MNA and TPM are both measures of raw transcript reads; however, direct comparison of the color intensity between the two heat maps is not necessarily meaningful. HAE were infected with MeV and collected for sequencing at 0, 0.5, 1, 2, 3, and 5 dpi. n = 4 donors. Heatmaps were constructed using RStudio. ( C–H ) qRT-PCR results of indicated genes from MeV-infected HAE 0.25–5 dpi. n = 3 donors.

    Journal: Microbiology Spectrum

    Article Title: Interferon-independent processes constrain measles virus cell-to-cell spread in primary human airway epithelial cells

    doi: 10.1128/spectrum.01361-23

    Figure Lengend Snippet: IFN RNA levels are not elevated during MeV infection of HAE. ( A ) Single-cell RNA sequencing was performed on mock or MeV-infected cultures 3 and 7 dpi. Each MeV-infected culture was FACS sorted into GFP+ or GFP− populations. Intensity shows measure of raw gene transcript counts normalized for the number of cells and total transcript reads in each group (MNA). Every condition included 10 pooled, matched donor HAE cultures, and sequencing was performed with a 10× Genomics scRNA-seq. ( B ) A heat map is shown depicting expression levels for selected innate immune genes measured by RNAseq of MeV-infected HAE. Transcript abundances are expressed as transcripts per million (TPM). MNA and TPM are both measures of raw transcript reads; however, direct comparison of the color intensity between the two heat maps is not necessarily meaningful. HAE were infected with MeV and collected for sequencing at 0, 0.5, 1, 2, 3, and 5 dpi. n = 4 donors. Heatmaps were constructed using RStudio. ( C–H ) qRT-PCR results of indicated genes from MeV-infected HAE 0.25–5 dpi. n = 3 donors.

    Article Snippet: To induce IFN-blocking, MeV-infected HAE cultures were treated apically with 2 μg/mL recombinant B18R protein (StemCell Technologies cat# 78075) or 50 ng/mL monoclonal anti-human IFN-λ1 neutralizing antibody (clone MMHLR1, PBL Assay Science, Piscataway, NJ, cat# 21885-1).

    Techniques: Infection, Single Cell, RNA Sequencing, Sequencing, Expressing, RNA sequencing, Comparison, Construct, Quantitative RT-PCR